Clinical Trials Browser

Phase 1/2 × Waldenstrom Macroglobulinemia × ibrutinib × Clear all

NCT04522284 2023-03-29

PRECISE CURATE.AI Pilot Clinical Trial

Phase 1/2 Unknown

Waldenstrom Macroglobulinemia, Neoplasms